NeuroBo Pharmaceuticals Inc

-0.04 (-0.74%)
Earnings Announcements

NeuroBo Pharmaceuticals Reports Q3 Loss Per Share Of $0.19

Published: 11/13/2020 21:40 GMT
(NRBO) - Neurobo Pharmaceuticals Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.19.
Expects That Its Cash Position Will Be Adequate to Fund Operations Into Q3 of 2021.
Cash and Cash Equivalents Were $12.4 Million As of September 30, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.